Developing a potent treatment for metal poisoning
metaLead has raised €1.2M across 2 funding rounds from 2 investors, most recently a round in May 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-05-06 | Other | €1.1M | UZH Life Sciences Fund (LSF) | View deal → |
| 2023-03-10 | Other | €153k | Venture Kick | View deal → |
